The novel therapy of this peptide represents a exciting breakthrough in the management of the condition. Different to existing drugs, tirzepatide impacts dual pathways – glucagon-like peptide-1 (GLP-1) and the GIP https://tirzepatidepeptide949157.loginblogin.com/50222513/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment